Clinical Trial

Pacifier Use During Phototherapy in Newborns With Hyperbilirubinemia

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 30, 2024 (before its estimated November 1, 2024 completion). Its status may not reflect the trial's current state.
Summary
Hyperbilirubinemia; It is a common condition that usually occurs physiologically in newborns. Phototherapy is used in the treatment of hyperbilirubinemia. Babies cry while receiving phototherapy, the mother's inability to hold her baby in her arms, her inability to breastfeed, and the invasive procedures (bloodletting) stress the baby. Pacifiers are used among individualized developmental care practices to calm the baby and reduce stress. Another benefit of pacifiers for the baby is on the gastrointestinal system. Non-nutritive sucking stimulates oro-motor development, facilitates the development of sucking behavior and facilitates digestion in enteral feeding. Considering all these benefits, this study aimed to determine the effect of pacifier use during phototherapy on stress and bilirubin levels in newborns with hyperbilirubinemia.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-07-06.
Trial Details
NCT Number NCT06498765
Lead Sponsor Hitit University
Conditions Newborn Jaundice, Pacifier
Enrollment 60 participants
Start Date 2023-06-01
Primary Completion 2024-11-01 (estimated)
Study Completion 2025-02-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-30